160 related articles for article (PubMed ID: 32922351)
1. Individual Treatment Decisions for Central Neurocytoma.
Han S; Yang Z; Yang Y; Qi X; Yan C; Yu C
Front Neurol; 2020; 11():834. PubMed ID: 32922351
[No Abstract] [Full Text] [Related]
2. Clinical Outcomes and Prognostic Analysis of 101 Patients of Central Neurocytoma: A 10-Year Treatment Experience at a Single Institution.
Xie Q; Xie B; Ou L; Wang M; Tang Z; He Y; Yang X; Hong J; Lyu Z; Wei R
Front Oncol; 2022; 12():881460. PubMed ID: 35692765
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features, Treatment, and Long-term Outcomes of Central Neurocytoma: A 20-Year Experience at a Single Center.
Wang M; Zhou P; Zhang S; Liu X; Lv L; Wang Z; Ye F; Wang X; Jiang S
World Neurosurg; 2018 Jan; 109():e59-e66. PubMed ID: 28958923
[TBL] [Abstract][Full Text] [Related]
4. Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.
She L; Deng D; Su L; Liu C
J Neurooncol; 2022 Nov; 160(2):455-462. PubMed ID: 36307664
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma.
Chen YD; Li WB; Feng J; Qiu XG
Radiat Oncol; 2014 Nov; 9():242. PubMed ID: 25373333
[TBL] [Abstract][Full Text] [Related]
6. Atypical Central Neurocytoma: An Investigation of Prognostic Factors.
AbdelBari Mattar M; Shebl AM; Toson EA
World Neurosurg; 2021 Feb; 146():e184-e193. PubMed ID: 33091649
[TBL] [Abstract][Full Text] [Related]
7. Impact of Adjuvant Radiotherapy in Patients with Central Neurocytoma: A Multicentric International Analysis.
Samhouri L; Meheissen MAM; Ibrahimi AKH; Al-Mousa A; Zeineddin M; Elkerm Y; Hassanein ZMA; Ismail AA; Elmansy H; Al-Hanaqta MM; Al-Azzam OA; Elsaid AA; Kittel C; Micke O; Stummer W; Elsayad K; Eich HT
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503124
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
[TBL] [Abstract][Full Text] [Related]
9. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas.
Rades D; Schild SE
Cancer; 2006 Mar; 106(5):1140-3. PubMed ID: 16400638
[TBL] [Abstract][Full Text] [Related]
10. [Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients].
Rades D; Fehlauer F; Schild S; Lamszus K; Alberti W
Strahlenther Onkol; 2003 Apr; 179(4):213-8. PubMed ID: 12707710
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
Imber BS; Braunstein SE; Wu FY; Nabavizadeh N; Boehling N; Weinberg VK; Tihan T; Barnes M; Mueller S; Butowski NA; Clarke JL; Chang SM; McDermott MM; Prados MD; Berger MS; Haas-Kogan DA
J Neurooncol; 2016 Jan; 126(1):193-200. PubMed ID: 26493740
[TBL] [Abstract][Full Text] [Related]
12. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
13. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
14. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.
Masalha W; Heiland DH; Franco P; Delev D; Haaker JG; Schnell O; Scheiwe C; Grauvogel J
J Neurooncol; 2018 Jan; 136(1):147-154. PubMed ID: 29081038
[TBL] [Abstract][Full Text] [Related]
15. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection.
Hardesty DA; Wolf AB; Brachman DG; McBride HL; Youssef E; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
J Neurosurg; 2013 Aug; 119(2):475-81. PubMed ID: 23394332
[TBL] [Abstract][Full Text] [Related]
16. Extraventricular Neurocytoma: Clinical Investigation of Heterogenous Prognosis.
Byun J; Kim M; Song SW; Kim YH; Hong CK; Kim JH
Brain Tumor Res Treat; 2022 Jan; 10(1):22-28. PubMed ID: 35118844
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.
Hemmati SM; Ghadjar P; Grün A; Badakhshi H; Zschaeck S; Senger C; Acker G; Misch M; Budach V; Kaul D
Radiat Oncol; 2019 Sep; 14(1):160. PubMed ID: 31477146
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated neurocytoma: what is the best available treatment?
Rades D; Fehlauer F; Lamszus K; Schild SE; Hagel C; Westphal M; Alberti W
Neuro Oncol; 2005 Jan; 7(1):77-83. PubMed ID: 15701284
[TBL] [Abstract][Full Text] [Related]
19. Effect comparisons among treatment measures on progression-free survival in patients with skull base chordomas: a retrospective study of 234 post-surgical cases.
Wang L; Tian K; Ma J; Wang K; Jia G; Wu Z; Zhang L; Zhang J
Acta Neurochir (Wien); 2017 Oct; 159(10):1803-1813. PubMed ID: 28699066
[TBL] [Abstract][Full Text] [Related]
20. The role of proton beam therapy in central neurocytoma: A single-institution experience.
Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
